Literature DB >> 11383734

Fluoroscopic frameless stereotaxy for transsphenoidal surgery.

J A Jane1, K Thapar, T D Alden, E R Laws.   

Abstract

OBJECTIVE: To assess the value of frameless fluoroscopy-guided stereotactic transsphenoidal surgery using the FluoroNav Virtual Fluoroscopy System (Medtronic Sofamor Danek, Inc., Memphis, TN).
METHODS: Twenty consecutive patients undergoing transsphenoidal surgery for sellar lesions were assigned to transsphenoidal surgery with or without computer-assisted fluoroscopic image guidance using the FluoroNav system. Prospective data regarding patient age, sex, lesion characteristics, operative time, and treatment cost were obtained.
RESULTS: Although patients in the FluoroNav group were, on average, 17 years younger than the patients in the control group, more patients with recurrent adenomas were treated in the image guidance group. No other significant differences between the groups were found. FluoroNav provided accurate, continuous information regarding the anatomic midline trajectory to the sella turcica as well as anatomic structures (e.g., sella, sphenoid sinus) in the lateral view. No patient required reversion to intraoperative videofluoroscopy. No statistically significant differences were found with regard to preincision setup time, operative time, or cost. FluoroNav allowed procedures to be performed with significantly fewer x-rays being taken.
CONCLUSION: Fluoroscopic computer-assisted frameless stereotaxy furnishes accurate real-time information with regard to midline structures and operative trajectory. Although it is useful in first-time transseptal transsphenoidal surgery, its primary benefit is realized in recurrent surgery.

Entities:  

Mesh:

Year:  2001        PMID: 11383734     DOI: 10.1097/00006123-200106000-00025

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  10 in total

1.  Device setting modifications for 3D flatpanel imaging in skull base surgery.

Authors:  Frederike Hassepass; Wolfgang Maier; Antje Aschendorff; Stefan Bulla; Werner Vach; Roland Laszig; Tanja D Grauvogel
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-04-06       Impact factor: 2.503

2.  The history of the treatment of pituitary adenomas.

Authors:  Nicholas F Maartens
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

3.  The use of image-guidance during transsphenoidal pituitary surgery in the United States.

Authors:  Thomas K Chung; Kristen O Riley; Bradford A Woodworth
Journal:  Am J Rhinol Allergy       Date:  2015 May-Jun       Impact factor: 2.467

Review 4.  Intraoperative magnetic resonance imaging during surgery for pituitary adenomas: pros and cons.

Authors:  Michael Buchfelder; Sven-Martin Schlaffer
Journal:  Endocrine       Date:  2012-07-26       Impact factor: 3.633

Review 5.  iMRI During Transsphenoidal Surgery.

Authors:  Prashant Chittiboina
Journal:  Neurosurg Clin N Am       Date:  2017-08-18       Impact factor: 2.509

6.  Accuracy of Surgeon's Estimation of Sella Margins during Endoscopic Surgery for Pituitary Adenomas: Verification Using Neuronavigation.

Authors:  Yi Yuen Wang; Wasiq A Thiryayi; Ragu Ramaswamy; Kanna K Gnanalingham
Journal:  Skull Base       Date:  2011-05

Review 7.  Pituitary tumor diagnosis and treatment.

Authors:  Paul L Penar; David J Nathan; Muriel H Nathan; Afshin Salsali
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

8.  Sellar, suprasellar, and parasellar masses: Imaging features and neurosurgical approaches.

Authors:  Bryan Lubomirsky; Zachary B Jenner; Morgan B Jude; Kiarash Shahlaie; Reza Assadsangabi; Vladimir Ivanovic
Journal:  Neuroradiol J       Date:  2021-12-02

Review 9.  Transsphenoidal surgery.

Authors:  Shabin Man Joshi; Simon Cudlip
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

10.  Cabergoline-induced fibrosis of prolactinomas: a neurosurgical perspective.

Authors:  Niraj Mohan; Yi Yan Chia; Giap Hean Goh; Eric Ting; Kejia Teo; Tseng Tsai Yeo
Journal:  BMJ Case Rep       Date:  2017-11-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.